Export

ATC codes: L01CA02
EMLc
Indication
Malignant neoplasms of kidney, except renal pelvis ICD11 code: 2D40.Z
INN
Vincristine
Medicine type
Chemical agent
List type
Complementary
Formulations
Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate) ; 5 mg in vial (vincristine sulfate) ; 1 mg per mL in vial (vincristine sulfate) ; 2 mg per 2 mL in vial (vincristine sulfate)
EML status history
First added in 2011 (TRS 965)
Changed in 2015 (TRS 994)
Changed in 2021 (TRS 1035)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Tags
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended the addition of new strength formulations of vincristine IV injection (1mg/mL and 2 mg/2mL) to the EML and EMLc.